HOME › Research Insight › Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) Dominated the Global Clinical Trial Management System Market in 2015
Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) Dominated the Global Clinical Trial Management System Market in 2015
With a robust product portfolio and diversified geographic presence and customer base, Oracle Corporation dominated the global CTMS market in 2015. Over the past three years, the company has been pursuing the strategy of product deployment to maintain its market leadership. This helped the company to enhance its customer base and visibility in the CTMS market. In February 2016, Bayer HealthCare (Germany) selected Oracle Siebel Clinical Trial Management System and Oracle Health Sciences Clinical Development Analytics to manage its clinical monitoring processes.
Medidata Solutions, Inc. (U.S.) held the second position in the CTMS market in 2015. The company is one of the leading providers of cloud (software-as-a-service) solutions. The company primarily adopts the strategy of partnerships to expand its presence in the CTMS market. In 2016, the company partnered with various customers such as LSK Global Pharma Services (South Korea), Southampton Clinical Trials Unit at the University of Southampton (U.K.), R&G Pharma Studies Co., Ltd. (China), and Celgene Corporation (U.S.).
Major developments are taking place in the field of cloud-based software platforms, owing to the rising demand of these solutions by pharmaceutical companies and CROs. Significant market players such as BioClinica, Inc. (U.S.), DATATRAK International, Inc. (U.S.), MedNet Solutions, Inc. (U.S.), Bio-Optronics Inc. (U.S.), and ERT (U.S.) have introduced several advanced cloud-based CTMS and enhanced their products to remain competitive in the market.
In the CTMS market, leading players have been adopting various strategies such as partnerships, agreements, and collaborations; new product launches and product enhancements; product deployment; mergers and acquisitions; and geographic expansions to increase their presence. New product launches and product enhancements was the most widely adopted strategy by market players in the CTMS market. It helped market players to improve the capabilities of their existing CTMS product portfolios as well as to launch cost-effective and advanced CTMS solutions in order to cater to customer requirements. Various market players, including PAREXEL International (U.S.), Bioclinica (U.S.), Bio-Optronics (U.S.), DATATRAK (U.S.), and Veeva Systems Inc. (U.S.) launched new CTMS solutions from 2013 to 2016.
Bio-Optronics (U.S.) was the most active player in the CTMS market. The company adopted product enhancements as its key business strategy to strengthen its footprint in the global CTMS solutions market. It enhanced its Clinical Conductor Clinical Trial Management System several times from 2013 to 2016. For instance, in April 2015, the company enhanced its Clinical Conductor Clinical Trial Management System to have a new functionality to better manage clinical research.
Clinical Trial Management System Market by End-user (Pharmaceutical & Biotechnology, Medical Device Companies, CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Service) - Global Forecast to 2021
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India